INOVIQ Ltd (ASX:IIQ – Get Rating) insider Philip (Phil) Powell acquired 19,481 shares of INOVIQ stock in a transaction dated Friday, March 3rd. The stock was bought at an average price of A$0.56 ($0.38) per share, for a total transaction of A$10,909.36 ($7,321.72).

Philip (Phil) Powell also recently made the following trade(s):

• On Monday, March 6th, Philip (Phil) Powell acquired 20,000 shares of INOVIQ stock. The stock was bought at an average price of A$0.57 ($0.38) per share, for a total transaction of A$11,400.00 ($7,651.01).
• On Wednesday, March 1st, Philip (Phil) Powell acquired 18,518 shares of INOVIQ stock. The stock was bought at an average price of A$0.54 ($0.36) per share, for a total transaction of A$9,999.72 ($6,711.22).

INOVIQ Price Performance

The company has a debt-to-equity ratio of 3.73, a current ratio of 5.28 and a quick ratio of 9.52.

INOVIQ Company Profile

(Get Rating)

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.

Further Reading

• REV Group Hits A Wall Despite Results And Outlook
• Oil Tankers In Buy Range After Breaking Out Of Bases
• United Natural Foods Under Delivered...Did the Market Overreact?
• Can Cricut Stock Jump Higher In 2023?
• 10 Best Consumer Staples ETFs

Receive News & Ratings for INOVIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INOVIQ and related companies with MarketBeat.com's FREE daily email newsletter.